Citigroup
CLB icon

Citigroup’s Core Laboratories CLB Stock Holding History

Citigroup’s Portfolio CLB Stock Details CLB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-5,000
Closed -$76K – 7391
2020
Q3 		$76K Sell
5,000
-1,400
-22% -$29.4K ﹤0.01% 5308
2020
Q2 		$130K Buy
6,400
+700
+12% +$12.5K ﹤0.01% 5351
2020
Q1 		$59K Sell
5,700
-1,100
-16% -$30.8K ﹤0.01% 5825
2019
Q4 		$256K Buy
6,800
+4,600
+209% +$207K ﹤0.01% 4975
2019
Q3 		$103K Buy
2,200
+600
+38% +$27.9K ﹤0.01% 5643
2019
Q2 		$84K Buy
1,600
+700
+78% +$41.1K ﹤0.01% 6025
2019
Q1 		$62K Sell
900
-300
-25% -$20.1K ﹤0.01% 6153
2018
Q4 		$72K Sell
1,200
-9,500
-89% -$820K ﹤0.01% 5928
2018
Q3 		$1.24M Buy
10,700
+9,300
+664% +$1.05M ﹤0.01% 3252
2018
Q2 		$177K Buy
1,400
+1,000
+250% +$122K ﹤0.01% 5180
2018
Q1 		$43K Sell
400
-6,700
-94% -$741K ﹤0.01% 6267
2017
Q4 		$778K Sell
7,100
-5,700
-45% -$569K ﹤0.01% 3606
2017
Q3 		$1.26M Buy
12,800
+9,300
+266% +$902K ﹤0.01% 3125
2017
Q2 		$354K Buy
3,500
+3,000
+600% +$323K ﹤0.01% 4303
2017
Q1 		$58K Sell
500
-2,000
-80% -$232K ﹤0.01% 5594
2016
Q4 		$300K Sell
2,500
-1,700
-40% -$188K ﹤0.01% 4929
2016
Q3 		$472K Buy
+4,200
New +$484K ﹤0.01% 3938
2016
Q2 		– Sell
-400
Closed -$45K – 7103
2016
Q1 		$45K Sell
400
-700
-64% -$72.7K ﹤0.01% 6162
2015
Q4 		$120K Buy
+1,100
New +$126K ﹤0.01% 5221
2015
Q3 		– Sell
-100
Closed -$11K – 7405
2015
Q2 		$11K Buy
+100
New +$12.1K ﹤0.01% 6405

Other funds holding CLB

Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
Heartland Advisors
Heartland Advisors Milwaukee, Wisconsin $2.08B AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Evergreen Capital Management
Evergreen Capital Management Bellevue, Washington $5.65B AUM 21.62% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $348B AUM 26.9% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
Creative Planning
Creative Planning Overland Park, Kansas $179B AUM 16.96% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $420B AUM 34.97% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return
CWA Asset Management Group
CWA Asset Management Group Naples, Florida $3.39B AUM 25.16% 1-Year Est. Return

Citigroup's CLB Position: Q3 2026 in Review

Citigroup reduced its Core Laboratories (CLB) stake by 88% in Q3 2026, selling an estimated $748K and leaving 8,886 shares worth $86.2K. The position accounts for ﹤0.01% of the portfolio, ranked #4519.

Citigroup first reported a position in CLB in Q2 2013 and has held it in 54 quarters since. The position peaked at $15.9M in Q2 2018. 84 funds tracked by Wall St. Rank hold CLB as of Q3 2026.

  • Citigroup held 8,886 shares of Core Laboratories worth $86.2K as of Q3 2026.
  • Citigroup sold 64,598 Core Laboratories shares in Q3 2026, an estimated $748K.
  • Core Laboratories made up ﹤0.01% of Citigroup's portfolio in Q3 2026, its #4519 holding.
  • Citigroup first reported a position in Core Laboratories in Q2 2013 and has held it in 54 quarters since.
  • Citigroup's Core Laboratories position peaked at $15.9M in Q2 2018.
  • 84 funds tracked by Wall St. Rank held Core Laboratories as of Q3 2026.

Based on Citigroup's 13F filing for Q3 2026, filed 4 Nov 2026.